RTA Laboratuvarlari Biyolojik (RTALB) - Total Liabilities

Latest as of June 2025: TL103.51 Million TRY ≈ $2.32 Million USD

Based on the latest financial reports, RTA Laboratuvarlari Biyolojik (RTALB) has total liabilities worth TL103.51 Million TRY (≈ $2.32 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore RTALB operating cash flow to assess how effectively this company generates cash.

RTA Laboratuvarlari Biyolojik - Total Liabilities Trend (2010–2024)

This chart illustrates how RTA Laboratuvarlari Biyolojik's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are RTA Laboratuvarlari Biyolojik's assets to evaluate the company's liquid asset resilience ratio.

RTA Laboratuvarlari Biyolojik Competitors by Total Liabilities

The table below lists competitors of RTA Laboratuvarlari Biyolojik ranked by their total liabilities.

Company Country Total Liabilities
Bantas Bandirma Ambalaj Sanayi ve Ticaret AS
IS:BNTAS
Turkey TL21.32 Million
Avonmore Capital & Management Services Limited
NSE:AVONMORE
India Rs841.60 Million
Vince Holding Corp
NYSE:VNCE
USA $189.68 Million
Revoil S.A
AT:REVOIL
Greece €103.35 Million
Inspirisys Solutions Limited
NSE:INSPIRISYS
India Rs2.32 Billion
Brand 24 SA
WAR:B24
Poland zł15.03 Million
Artea SA
PA:ARTE
France €236.12 Million
EP Manufacturing Bhd
KLSE:7773
Malaysia RM285.93 Million

Liability Composition Analysis (2010–2024)

This chart breaks down RTA Laboratuvarlari Biyolojik's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of RTA Laboratuvarlari Biyolojik.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.24 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.05 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RTA Laboratuvarlari Biyolojik's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RTA Laboratuvarlari Biyolojik (2010–2024)

The table below shows the annual total liabilities of RTA Laboratuvarlari Biyolojik from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 TL252.17 Million
≈ $5.65 Million
+34.30%
2023-12-31 TL187.77 Million
≈ $4.21 Million
+74.71%
2022-12-31 TL107.47 Million
≈ $2.41 Million
-48.62%
2021-12-31 TL209.17 Million
≈ $4.68 Million
+135.77%
2020-12-31 TL88.72 Million
≈ $1.99 Million
+673.78%
2019-12-31 TL11.47 Million
≈ $256.80K
+27.53%
2018-12-31 TL8.99 Million
≈ $201.36K
+1.68%
2017-12-31 TL8.84 Million
≈ $198.03K
-17.29%
2016-12-31 TL10.69 Million
≈ $239.43K
-28.15%
2015-12-31 TL14.88 Million
≈ $333.23K
+30.52%
2014-12-31 TL11.40 Million
≈ $255.31K
+33.81%
2013-12-31 TL8.52 Million
≈ $190.80K
-9.94%
2012-12-31 TL9.46 Million
≈ $211.86K
+47.52%
2011-12-31 TL6.41 Million
≈ $143.61K
+18.89%
2010-12-31 TL5.39 Million
≈ $120.79K
--

About RTA Laboratuvarlari Biyolojik

IS:RTALB Turkey Biotechnology
Market Cap
$37.07 Million
TL1.66 Billion TRY
Market Cap Rank
#22971 Global
#408 in Turkey
Share Price
TL3.31
Change (1 day)
+1.85%
52-Week Range
TL2.60 - TL4.52
All Time High
TL29.60
About

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, paint… Read more